F Oberling
- Genetics top 0.5%
- Chronic Lymphocytic Leukemia Research 10
-
- Lymphoma Diagnosis and Treatment 13
- Immunology top 2%
- Immune Cell Function and Interaction 10
- Immunotherapy and Immune Responses 10
- Hematology top 2%
- Chronic Myeloid Leukemia Treatments 6
- Oncology top 5%
- Neutropenia and Cancer Infections 6
- Cancer Treatment and Pharmacology 6
-
- Ovarian cancer diagnosis and treatment 7
- Partner nations
- FranceSwitzerlandUnited States
In The Last Decade
F Oberling
105 papers receiving 2.7k citations
Hit Papers
Peers
Comparison fields: 5 of 112
- Genetics 1.4k
- Pathology and Forensic Medicine 1.1k
- Immunology 973
- Hematology 394
- Oncology 522
Countries citing papers authored by F Oberling
This map shows the geographic impact of F Oberling's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by F Oberling with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites F Oberling more than expected).
Fields of papers citing papers by F Oberling
This network shows the impact of papers produced by F Oberling. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by F Oberling. The network helps show where F Oberling may publish in the future.
Co-authorship network
The 25 scholars most cited alongside F Oberling, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 1997 | 18 | |
| 2 | 1997 | 5 | |
| 3 | 1996 | 18 | |
| 4 | 1996 | 7 | |
| 5 | Intra-abdominal localization of acute leukaemia: report of six cases. | 1995 | 2 |
| 6 | 1994 | 58 | |
| 7 | Cancer du sein après maladie de Hodgkin. Analyse de 6 observations. | 1993 | 0 |
| 8 | 1993 | 1 | |
| 9 | 1991 | 2 | |
| 10 | Hautes doses d'alkylants et autogreffe de moelle dans les cancers de l'ovaire à mauvais pronostic : une analyse rétrospective de 40 patientes traitées en France | 1990 | 0 |
| 11 | 1990 | 55 | |
| 12 | 1990 | 4 | |
| 13 | 1989 | 7 | |
| 14 | 1988 | 20 | |
| 15 | 1988 | 35 | |
| 16 | Choriocarcinome médiastinal au cours de l'évolution d'une leucose aiguë myeloblastique. | 1985 | 1 |
| 17 | 1984 | 12 | |
| 18 | Maladie de Hodgkin. Déficit lymphocytaire thymo-dépendant chez des patients en rémission complète. | 1978 | 2 |
| 19 | Normal active rosette-forming-cells in untreated patients with Hodgkin's disease. | 1977 | 4 |
| 20 | 1976 | 40 |
About F Oberling
F Oberling is a scholar working on Hematology, Genetics and Pathology and Forensic Medicine, having authored 111 papers that have together received 2.9k indexed citations. Recurring topics across this work include Lymphoma Diagnosis and Treatment (13 papers), Chronic Lymphocytic Leukemia Research (10 papers), Immune Cell Function and Interaction (10 papers), Immunotherapy and Immune Responses (10 papers), Ovarian cancer diagnosis and treatment (7 papers), Neutropenia and Cancer Infections (6 papers), Cancer Treatment and Pharmacology (6 papers) and Chronic Myeloid Leukemia Treatments (6 papers). The work is most often cited by research in Genetics (1.4k citations), Pathology and Forensic Medicine (1.1k citations) and Immunology (973 citations). F Oberling has collaborated with scholars based in France, Switzerland and United States. Frequent co-authors include J L Binet, Claude Lesty, M. Thomas, G Vaugier, F Grémy, G Potron, H Piguet, Guillaume Dighiero, M. Monconduit and J. Goasguen. Their work appears in journals such as Cancer, Cancer Immunology Immunotherapy, Leukemia Research, Annals of Oncology and Annals of Hematology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.